ArticleTranslational vision science & technology2023
Quotidian Profile of Vergence Angle in Ambulatory Subjects Monitored With Wearable Eye Tracking Glasses.
Article in Translational vision science & technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Bringing usability testing to the front lines: IV smart pump evaluation with critical care nurses at a national conference.MethodsX · 2026Article
- Gaze and gait dynamics are shaped by terrain type during urban walking.Scientific reports · 2026Article
- Usability Validation of an Integrated Hemodynamic and Pulmonary Monitoring System Using Eye-Tracking Analysis.Journal of clinical medicine · 2026Article
- Distribution of Globe Excursions Within the Orbits Monitored by Eye Tracking Glasses in Ambulatory Subjects Engaged in Their Normal Daily Activities.Investigative ophthalmology & visual science · 2025Article
- Ambulatory Monitoring With Eye Tracking Glasses to Assess the Severity of Intermittent Exotropia.American journal of ophthalmology · 2023Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Purpose: Wearable eye trackers record gaze position as ambulatory subjects navigate their environment. Tobii Pro Glasses 3 were tested to assess their accuracy and precision in the measurement of vergence angle. Methods: Four subjects wore the eye tracking glasses, with their head stabilized, while fixating at a series of distances corresponding to vergence demands of: 0.25, 0.50, 1, 2, 4, 8, 16, and 32°. After these laboratory trials were completed, 10 subjects wore the glasses for a prolonged period while carrying out their customary daily pursuits. A vergence profile was compiled for each subject and compared with interpupillary distance. Results: In the laboratory, the eye tracking glasses were comparable in accuracy to remote video eye trackers, outputting a mean vergence value within 1° of demand at all angles except 32°. In ambulatory subjects, the glasses were less accurate, due to tracking interruptions and measurement errors, partly mitigated by the application of data filters. Nonetheless, a useful record of vergence behavior was obtained in every subject. Vergence profiles often had a bimodal distribution, reflecting a preponderance of activities at near (mobile phone and computer) or far (driving and walking). As expected, vergence angle correlated with interpupillary distance. Conclusions: Wearable eye tracking glasses make it possible to compile a nearly continuous record of vergence angle over hours, which can be correlated with the corresponding visual scene viewed by ambulatory subjects. Translational Relevance: This technology provides new insight into the diversity of human ocular motor behavior and may become useful for the diagnosis of disorders that affect vergence function such as: convergence insufficiency, Parkinson disease, and strabismus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.